ISR Market Research (ISR), a ramarketing Group company, is developing an AI-enabled interface for its specialist pharmaceutical outsourcing research library, to give pharma companies access to the latest intel
Takara Bio USA and SPT Labtech has announced their partnership to deliver automated library preparation workflows that combine Takara Bio next-gen sequencing library preparation chemistries with SPT Labtech’s firefly liquid handling platform.
Antibody-drug conjugates (ADCs) have transformed oncology therapeutics by combining the selectivity of monoclonal antibodies with the potency of highly cytotoxic small-molecule drugs. Rongrong Li, senior principal scientist, WuXi AppTec discusses.
OGT, a provider of genomic research and diagnostic solutions has unveiled next-generation sequencing (NGS) automation capabilities across its SureSeq NGS portfolio, compatible with the Hamilton NGS STAR Line.
Oncodesign Services and Nexus BioQuest have formed a partnership connecting their respective in vitro and in vivo expertise, giving biotech companies a clearer route to specialist support as preclinical programs progress.
MedPharm has announced that it has become an Olink Certified Service Provider (CSP), making it the first Olink CSP in the Carolinas and one of only three in the Southeastern United States.
Dr. Janik Kaufmann, technical sales specialist Oligonucleotides, Hongene Biotech, looks at why chemoenzymatic technologies are moving into the spotlight.
CN Bio, a provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, has announced it has been awarded £180k grant funding from Innovate UK.
Antibody-drug conjugates (ADCs) are advancing cancer treatment, but their success depends on early safety insights and informed toxicology strategies. Xiaoxiao Wang, Yan Zhang, Junli Zhao, WuXi AppTec explains.
Imperial Brands Science examines how Toxicity Testing is helping to reshape biological testing by focusing on the mechanisms that drive toxicity and disease, and what this could mean for future product development and consumer safeguarding.
